Skip to main content
NVDA+0.60%AAPL-0.90%GOOGL-1.43%MSFT-1.10%AMZN-1.92%TSM-1.01%SPCX-2.24%META-0.20%AVGO-1.05%TSLA-0.39%SKHY+0.55%BRK-B+0.16%LLY+0.35%MU+0.73%JPM-0.87%WMT-0.16%AMD+2.21%V-0.56%XOM+1.44%JNJ-1.00%ASMLa-1.32%0700.HK+1.90%MA-0.77%INTC+1.34%ABBV-0.09%1398.HK-2.09%CSCO+0.56%CVX+1.27%BAC+0.08%ORCL-1.02%COST-1.12%KO-0.63%DELL+4.46%CAT-0.83%HSBA.L-1.54%0005.HK-3.21%PG+0.42%UNH-1.58%LRCX-2.38%AP2d-2.39%AMAT-1.27%1816.HK-0.46%3988.HK-2.13%NFLX-2.92%GE-2.42%MS-2.13%0857.HK+0.60%HD-1.40%PM-0.19%0939.HK-2.83%USDJPY+0.96%NZDUSD-0.92%USDTHB+0.72%CHFJPY+0.70%GBPNZD+0.68%GBPJPY+0.68%CADJPY+0.66%NZDCAD-0.63%NZDCHF-0.59%AUDUSD-0.57%EURNZD+0.47%EURUSD-0.46%EURJPY+0.46%GBPTRY+0.41%AUDJPY+0.40%NOKJPY+0.37%PLNJPY+0.36%AUDNZD+0.36%USDCHF+0.34%GBPHKD+0.32%GBPAUD+0.31%USDCAD+0.30%NZDMXN-0.29%GBPMXN-0.28%SGDJPY+0.27%AUDCAD-0.26%USDTRY+0.25%GBPUSD-0.25%AUDCHF-0.22%EURCAD-0.19%EURGBP-0.19%USDSGD+0.18%USDSEK+0.17%USDILS+0.16%CHFNOK-0.16%EURSGD+0.15%NZDSGD-0.14%EURSEK+0.14%EURCZK+0.13%EURAUD+0.12%GBPSGD+0.12%EURCHF-0.11%AUDDKK-0.10%USDPLN+0.08%USDCNH+0.08%USDNOK+0.08%GBPCHF+0.07%AUDNOK-0.06%CHFSEK-0.06%CHFSGD-0.05%GBPCAD+0.05%EURPLN+0.05%AUDSGD+0.05%USDCOP-0.04%EURNOK+0.04%USDMXN+0.04%NZDJPY+0.03%CADCHF+0.03%USDZAR+0.03%GBPZAR-0.03%USDDKK+0.03%EURHKD-0.03%USDHKD+0.02%EURCNH+0.02%EURDKK-0.01%EURZAR0.00%USOIL+2.40%W1+1.74%UKOIL+1.67%XNGUSD+1.22%COFFEE-1.13%SUGAR-0.85%C1+0.82%S1+0.79%COCOA-0.48%XAUUSD-0.46%GAUUSD-0.46%COTTON-0.34%BTCUSD-2.92%ETHUSD-4.53%USDTUSD-0.05%XRPUSD-3.05%SOLUSD-3.91%TRXUSDT-0.44%ZECUSDT-4.69%DOGEUSD-2.98%XMRUSDT-0.21%LINKUSD-3.40%XLMUSD-0.81%BCHUSDT-2.42%UNIUSD-4.53%LTCUSD-3.15%HBARUSDT-0.65%TONUSD+26.79%SUIUSD-3.74%TAOUSDT-4.06%AAVEUSD-3.45%DOTUSDT-2.61%ICPUSDT-7.65%ONDOUSDT-4.42%WLDUSDT-2.62%ARBUSDT+2.49%ATOMUSDT-2.10%JUPUSDT-5.56%INJUSDT-9.79%STXUSDT-3.87%FETUSDT-4.96%PYTHUSDT-5.29%TIAUSDT-6.99%SEIUSDT-4.71%IMXUSDT-2.62%OPUSDT-3.66%GRTUSDT-4.64%WIFUSDT-5.33%POLUSDT-0.67%IOTAUSDT-6.37%AXSUSDT-3.83%FARTCOINUSDT-2.70%EOSUSDT-4.69%DYDXUSDT-7.05%ORDIUSDT-2.79%GALAUSDT-2.65%NOTUSDT-2.37%RONINUSDT-7.55%NVDA+0.60%AAPL-0.90%GOOGL-1.43%MSFT-1.10%AMZN-1.92%TSM-1.01%SPCX-2.24%META-0.20%AVGO-1.05%TSLA-0.39%SKHY+0.55%BRK-B+0.16%LLY+0.35%MU+0.73%JPM-0.87%WMT-0.16%AMD+2.21%V-0.56%XOM+1.44%JNJ-1.00%ASMLa-1.32%0700.HK+1.90%MA-0.77%INTC+1.34%ABBV-0.09%1398.HK-2.09%CSCO+0.56%CVX+1.27%BAC+0.08%ORCL-1.02%COST-1.12%KO-0.63%DELL+4.46%CAT-0.83%HSBA.L-1.54%0005.HK-3.21%PG+0.42%UNH-1.58%LRCX-2.38%AP2d-2.39%AMAT-1.27%1816.HK-0.46%3988.HK-2.13%NFLX-2.92%GE-2.42%MS-2.13%0857.HK+0.60%HD-1.40%PM-0.19%0939.HK-2.83%USDJPY+0.96%NZDUSD-0.92%USDTHB+0.72%CHFJPY+0.70%GBPNZD+0.68%GBPJPY+0.68%CADJPY+0.66%NZDCAD-0.63%NZDCHF-0.59%AUDUSD-0.57%EURNZD+0.47%EURUSD-0.46%EURJPY+0.46%GBPTRY+0.41%AUDJPY+0.40%NOKJPY+0.37%PLNJPY+0.36%AUDNZD+0.36%USDCHF+0.34%GBPHKD+0.32%GBPAUD+0.31%USDCAD+0.30%NZDMXN-0.29%GBPMXN-0.28%SGDJPY+0.27%AUDCAD-0.26%USDTRY+0.25%GBPUSD-0.25%AUDCHF-0.22%EURCAD-0.19%EURGBP-0.19%USDSGD+0.18%USDSEK+0.17%USDILS+0.16%CHFNOK-0.16%EURSGD+0.15%NZDSGD-0.14%EURSEK+0.14%EURCZK+0.13%EURAUD+0.12%GBPSGD+0.12%EURCHF-0.11%AUDDKK-0.10%USDPLN+0.08%USDCNH+0.08%USDNOK+0.08%GBPCHF+0.07%AUDNOK-0.06%CHFSEK-0.06%CHFSGD-0.05%GBPCAD+0.05%EURPLN+0.05%AUDSGD+0.05%USDCOP-0.04%EURNOK+0.04%USDMXN+0.04%NZDJPY+0.03%CADCHF+0.03%USDZAR+0.03%GBPZAR-0.03%USDDKK+0.03%EURHKD-0.03%USDHKD+0.02%EURCNH+0.02%EURDKK-0.01%EURZAR0.00%USOIL+2.40%W1+1.74%UKOIL+1.67%XNGUSD+1.22%COFFEE-1.13%SUGAR-0.85%C1+0.82%S1+0.79%COCOA-0.48%XAUUSD-0.46%GAUUSD-0.46%COTTON-0.34%BTCUSD-2.92%ETHUSD-4.53%USDTUSD-0.05%XRPUSD-3.05%SOLUSD-3.91%TRXUSDT-0.44%ZECUSDT-4.69%DOGEUSD-2.98%XMRUSDT-0.21%LINKUSD-3.40%XLMUSD-0.81%BCHUSDT-2.42%UNIUSD-4.53%LTCUSD-3.15%HBARUSDT-0.65%TONUSD+26.79%SUIUSD-3.74%TAOUSDT-4.06%AAVEUSD-3.45%DOTUSDT-2.61%ICPUSDT-7.65%ONDOUSDT-4.42%WLDUSDT-2.62%ARBUSDT+2.49%ATOMUSDT-2.10%JUPUSDT-5.56%INJUSDT-9.79%STXUSDT-3.87%FETUSDT-4.96%PYTHUSDT-5.29%TIAUSDT-6.99%SEIUSDT-4.71%IMXUSDT-2.62%OPUSDT-3.66%GRTUSDT-4.64%WIFUSDT-5.33%POLUSDT-0.67%IOTAUSDT-6.37%AXSUSDT-3.83%FARTCOINUSDT-2.70%EOSUSDT-4.69%DYDXUSDT-7.05%ORDIUSDT-2.79%GALAUSDT-2.65%NOTUSDT-2.37%RONINUSDT-7.55%
CT

Celldex Therapeutics, Inc. (CLDX)

NASDAQ • Healthcare

$39.18
+$2.28 (+6.2%)
Market open

Last close at September 14, 2026 at 20:00 UTC

Open$37.4
Previous Close$39.18
Day Range$37.27 - $39.42
Avg. Volume (3M)709.9K
Market Cap$2.5B
52 Week Range
$22.1$45.14
Next EarningsIn 55 daysNov 9, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$22K100%
Gross Profitminus cost of goods$22K100%

Fundamentals & Financials

Revenue (TTM)
$112K
Net Income (TTM)
-$300.5M
EPS (TTM)
-$4.36
ROA (TTM)
-38.42%
Current Ratio
11.82

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-22.0%Q1 2026-$1.22
-2.9%Q2 2026-$1.18
+11.3%Q3 2026-$0.94
Next

Nov 9

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +11.3%

Celldex Therapeutics topped EPS expectations as revenue fell sharply year over year in the second fiscal quarter of 2026, reported August 6, 2026. EPS of -$0.94 topped the -$1.06 estimate by $0.12, while revenue fell 97% to about $0.0 million from $730,000.00 a year ago. With gross profit also about $0.0 million, the quarter produced an operating loss of roughly $80.6 million and a net loss of about $73.5 million, narrowing ~30% from a net loss of -$56.6 million a year ago, alongside EPS down 11% from -$0.85. The company remains focused on its antibody-based pipeline, including candidates such as CDX-0159, CDX-1140, and CDX-527, rather than marketed products. For the next period, consensus calls for EPS of -$1.02 on revenue of $725,750.00.

View full earnings history

About Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. develops antibody-based treatments as a biotechnology company in the healthcare sector and trades on the NASDAQ under CLDX. Founded in 1983, Celldex is a small-cap drug developer focused on monoclonal and bispecific antibodies aimed at inflammatory diseases and cancers.

Name
Celldex Therapeutics, Inc.
CEO
Anthony S. Marucci
Website
www.celldex.com
Industry
Healthcare
Year Founded
1983
Employees
198

Today's Snapshot

AI-generated

The session opened with CLDX slightly lower at 39.00, while its sector was flat.

Trading Volume

Below 10d avg (640.4K)

154.8K

vs S&P 500 Today

Underperforming Market

-2.45%

Updated: September 15, 2026 at 15:06 UTC

Technical Indicators

2 Buy2 Neutral4 Sell
CLDX leans bearish as price remains below its short- and medium-term averages while momentum indicators including MACD and CCI are negative, signaling selling pressure. The ADX is low, indicating a weak trend rather than a strong directional move, and volatility is moderate by ATR. Notably, longer-term averages sit beneath current price, which tempers the sell signal, but on-balance volume is negative, reinforcing distribution. Classic pivot is slightly higher, marking nearby resistance. Technical takeaway: Sell — short-term momentum and volume favor the downside despite longer-term support levels.
All signals
  • EMA (5 indicators)$32.82 - $39.26
    Sell
  • RSI (14)43.62
    Neutral
  • Stochastic %K (14, 3, 3)22.41
    Neutral
  • MACD Level (12, 26)-0.38
    Sell

Peers & Related Assets

SYRESpyre Therapeutics, Inc.
$90.8+0.2%
VERAVera Therapeutics, Inc.
$34.05-2.9%
HRMYHarmony Biosciences Holdings, Inc.
$41.54+0.1%
IMNMImmunome, Inc.
$24.55-0.5%
NUVBNuvation Bio Inc.
$5.94-2.1%
BHVNBiohaven Ltd.
$12.64-0.6%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.